You'll have a call for every read covering that site, note the depth column. While Phred scores are just log10 values, they're usually encoded in ASCII by first adding 33 to the Phred score. The information provided in a pileup won't be useful for splicing, but it could help with finding RNA editing and other modifications (at least if they're observable in sequencing). Whether you want to use the pileup or just the VCF is sort of up to you.
Unconfigured Ad
Collapse
X
-
ok I understood the output that mpileup give me.
Now I think that should exist a "script" to translate the output.. I mean: if I have ....,. in the output it means I have 6 reads in total in that X position in which 5 reads are forward and 1 is reverse. I think that for a normal py script, to do this kind of translation could be easy..
Comment
-
before starting to make a script, I tried VarScan..
Reading input from Pileup_merge.pileup (VARSCAN)
chrM 1 G 4 3 G:3:1:21:1:0:3:0
chrM 2 G 4 4 G:4:1:24:1:0:4:0
chrM 3 A 4 4 A:4:1:24:1:0:4:0
chrM 4 T 4 3 T:3:1:23:1:0:3:0
chrM 5 C 2 1 C:1:1:24:1:0:1:0
chrM 6 C 4 3 C:3:1:23:1:0:3:0
mpileup file:
chrM 1 G 4 ^*,^7,^7,^*, 5529
chrM 2 G 4 ,,,, 7;8=
chrM 3 A 4 ,,,, 7:7=
chrM 4 T 4 ,,,, 465=
chrM 5 C 2 ,, 19
chrM 6 C 4 ,,,, 465=
A part that VARSCAN give me error after 300 positions (I ll think after about this error), I don t see the link between these 2 output..
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:52 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Comment